Kent R. Van Kampen

Papers

1

Total Citations

94

H-Index

1

About

Kent R. Van Kampen is a pioneering virologist and vaccinologist whose work has significantly advanced the field of avian influenza prevention. His research focuses on innovative vaccine delivery systems, particularly the use of non-replicating human adenovirus vectors for in ovo vaccination—a method that immunizes chicks before they hatch. His most-cited paper, "Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector" (2006, 94 citations), demonstrates a breakthrough approach to protecting poultry from highly pathogenic strains. By leveraging adenovirus vectors, Van Kampen’s work bypasses traditional vaccine limitations, offering rapid, scalable, and safe immunization that reduces disease spread in flocks. This contribution has implications for both food security and pandemic preparedness, as avian influenza poses zoonotic risks. His research underscores the potential of vector-based vaccines in veterinary medicine, inspiring further studies on cross-species protection. Van Kampen’s achievements highlight his role in bridging molecular biology and practical veterinary applications, making him a key figure in the fight against emerging viral threats.

Research Focus

Key Achievements

1
H-Index
1
Papers
94
Total Citations
94
Avg Citations/Paper
🏆 Most Cited Paper
Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector
94 citations · 2006
📈 Most Prolific Year: 2006 (1 Papers)
🤝 Key Collaborators: 5

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago